Detail
LncRNA Name | FAM83H-AS1 |
Synonyms | FAM83H-AS1, onco-lncRNA-3 |
Region | NA Sequence |
Ensembl | NA |
RefSeq | NR_033849 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | glioma |
ICD-0-3 | M9380/3 |
Methods | qPCR, RIP, Western blot etc. |
Sample | glioma tissues, cell line (U87 and U251) |
Expression Pattern | up-regulated |
Function Description | FAM83H-AS1 was upregulated in glioma tissues and cell lines and high level of FAM83H-AS1 was associated with poor prognosis of glioma. Loss-of-function assays demonstrated that silenced FAM83H-AS1 obviously suppressed cell proliferation via regulating the cell-cycle distribution and cell apoptosis rate, and mechanistic experiments revealed that FAM83H-AS1 could epidemically silence CDKN1A expression through recruiting EZH2 to the promoter of CDKN1A, thereby influencing the cell cycle and proliferation. Moreover, the the Kaplanâ??Meier method (log-rank test) was used to analyze the correlation between FAM83HAS1 expression and overall survival of all patients and we found that high level of FAM83Hâ??AS1 was associated with poor prognosis ( p < 0.001, log-rank test). |
Pubmed ID | 29870057 |
Year | 2018 |
Title | Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21). |
External Links |
Links for FAM83H-AS1 | GenBank HGNC lncrnadb Noncode |
Links for glioma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.